Thank you very much, Chair. I'll be sharing my time with Dr. Powlowski, if that's okay with you.
I want to thank all of the witnesses for being here, particularly Dr. Seely, whom I had the opportunity to meet a little over a year ago on precisely this issue. I'm thankful to her for the guidance that she gave me on the task force work.
Since that time, the issue of breast cancer and screening has become personal to me, as my mother was diagnosed with breast cancer. Although she's an older woman, it was screening that caught her cancer in its very early stages, and she's on an incredible journey of recovery and living her full life.
I must say that I feel very frustrated by the draft guidelines the task force has issued and I am thankful that this committee is doing the important work and listening to witnesses.
Dr. Seely, when we met, you spoke about a study you had done, I believe in 2023, that looked at how screening of women aged 40 to 49 impacted net survival. Would you be able to elaborate for us on some of the key findings and why you believe the screening age should be lowered to 40?